StonvexLoading…
StonvexStonvexStonvexCore line items from ETN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $27.45B | $24.88B | $23.20B | $20.75B |
Operating Income | $4.93B | $4.57B | $3.83B | $2.91B |
Net Income | $4.09B | $3.79B | $3.22B | $2.46B |
EPS (Diluted) | $10.45 | $9.50 | $8.02 | $6.14 |
Total Assets | $41.25B | $38.38B | $38.43B | $35.01B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $622.00M | $555.00M | $488.00M | $294.00M |
Free Cash Flow OCF − CapEx | $3.55B | $3.52B | $2.87B | $1.94B |
Shares Outstanding | 387.90M | 392.90M | 399.40M | 397.80M |